CTRI/2009/091/000611已完成3 期
Evaluation of efficacy and safety of febuxostat versus allopurinol in chronic management of hyperuricemia in patients with gout: a randomized, open label, comparative, active controlled, multicentric study.
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Male or female patients aged between 18 and 65 years.
- •2.Patients with gout and with serum urate concentration of at least 8.0 mg/dl.
- •3.Patient willing to give their informed consent
排除标准
- •1.Pregnant, lactating women or women of childbearing age who are not using an acceptable method of birth control.
- •2.Patients treated with azathioprine, mercaptopurine, and theophylline.
- •3.Patients being on cytotoxic chemotherapy.
- •4.Patients who are hypersensitive to Febuxostat or Allopurinol.
- •5.Patients with hypertension or cardiac insufficiency.
研究者
相似试验
招募中
3 期
the effect of febuxostat in sepsisIRCT20230814059148N1Tabriz University of Medical Sciences40
暂停
4 期
Observation Of Clinical Efficacy And Safety Of Bufonis Venenum Injection In The Treatment Of Severe Novel Coronavirus Pneumonia (COVID-19)ITMCTR2000003105The First People's Hospital of Jiangxia District, Wuhan
已完成
不适用
Study of the effects of febuxostat in patients with diabetic nephropathy.Diabetic nephropathyJPRN-UMIN000015547Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine50
已完成
不适用
A study to evaluate the effect of febuxostat in heart failure patients with hyperuricemiaHeart failureJPRN-UMIN000021919Kochi Medical School, Kochi University200
已完成
4 期
Effect of febuxostat on disease progression in patients of chronic kidney disease with high uric acid levels in the blood.CTRI/2014/08/004853Institute of Postgraduate Medical Education and Research Kolkata93